January 30, 2025
Jan. 29, 2025 — Researchers at Ochsner Health, led by Hernan Bazan, MD, DFSVS, FACS, have developed a predictive model…
January 30, 2025
Penumbra recently launched its Element Vascular Access System, a laser-cut hypotube sheath designed for venous…
January 30, 2025
Jan. 29, 2025 – Scandinavian Real Heart AB (recently aannounced that its total artificial heart, Realheart TAH, has…
January 29, 2025
Jan. 16, 2025 — Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable…
January 29, 2025
Jan. 28, 2025 — Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular…
January 28, 2025
Jan. 28. 2025 — Researchers have developed a new software tool that provides unprecedented capabilities to see inside…
January 27, 2025
Jan. 25, 2025—A new study presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that…
January 27, 2025
Jan. 13, 2025 — Medtronic recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a…
January 24, 2025
Jan. 24, 2025 — In-patients undergoing coronary artery bypass grafting (CABG), a novel analysis evaluating surgeon…
January 24, 2025
Jan. 22, 2025 – Anthos Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat …
January 23, 2025
Jan. 22, 2025 — Public Responsibility in Medicine and Research (PRIM&R) recently called for establishing clear…
January 23, 2025
Jan. 22, 2025 -- HeartFlow, Inc., a provider of non-invasive artificial intelligence (AI) heart care solutions, and …
January 14, 2025
Jan. 9, 2025 — Gender-based racism through microaggressions may be linked to higher blood pressure postpartum and…
January 14, 2025
Jan. 13, 2025 — Medtronic plc recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening…
January 14, 2025
Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk…
January 13, 2025
Jan. 13, 2025 – R3 Vascular Inc., a medical device company dedicated to treating peripheral arterial disease (PAD),…
January 13, 2025
A new study reports persistent disparities in outcomes for people with peripheral artery disease (PAD) and its more…
January 13, 2025
Jan. 13, 2025 -- ERS Genomics, the CRISPR licensing company, has announced the launch of its Express License platform…
January 08, 2025
Jan. 8, 2025 — Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing medicines…
January 07, 2025
Jan. 7, 2025 — FIRE1 recently announced it has received Breakthrough Device Designation from the U.S. Food and Drug…
